Art

J-GLOBAL ID：200902211880650370   Reference number：06A0855395

Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: A preliminary study

慢性C型肝炎患者に対する二重濾過プラスマフェレーシス(DFPP)とインターフェロン療法の併用におけるウイルス学的効果と安全性 予備試験

Author (11)： YAMASHITA Tatsuya (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  ARAI Kuniaki (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  SAKAI Akito (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  MIZUKOSHI Eishiro (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  SAKAI Yoshio (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  KAGAYA Takashi (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  NAKAMOTO Yasunari (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  HONDA Masao (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  WADA Takashi (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  YOKOYAMA Hitoshi (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...) ,  KANEKO Shuichi (Dep. of Gastroenterology and Nephrology, Kanazawa Univ. Graduate School of Medical Sci., 13-1 Takara-Machi, Kanazawa ...)
Material： Hepatology Research  (Hepatol Res)
Volume： 36  Issue： 3  Page： 167-175  Publication year： Nov. 2006 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： double filtration plasmapheresis

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0855395&from=J-GLOBAL&jstjournalNo=W1284A") }}

JST classification (3)： Treatment for digestive system diseases in general  (GH05010V) ,  Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G) ,  Clinical application of antiviral drugs  (GW17050Z)

Substance index (1)： Ribavirin

Reference (30)：

• YOSHIDA, H. Interferon therapy reduces the risk for hepatocellular carcinoma : national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy. Ann Intern Med. 1999, 131, 174-181
• MCHUTCHISON, JG. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998, 339, 1485-1492
• IINO, S. Comparison of ribavirin (SCH18908) and interferon α-2b combination therapy and interferon α-2b monotherapy in chronic hepatitis C patients of genotype 1b and high viral load-a double blind parallel study to determine dosage and administration. Rinsyou Iyaku (J Clin Therap Med). 2002, 18, 565-591
• POYNARD, T. Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet. 1998, 352, 1426-1432
• POYNARD, T. Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group. Hepatology. 2000, 31, 211-218

Terms in the title (10)： 慢性C型肝炎 ,  患者 ,  濾過 ,  プラスマフェレーシス ,  DFPP ,  インターフェロン療法 ,  併用 ,  ウイルス学 ,  安全性 ,  試験